ATE555656T1 - Verwendung von seh-hemmern als analgetika - Google Patents

Verwendung von seh-hemmern als analgetika

Info

Publication number
ATE555656T1
ATE555656T1 AT06813607T AT06813607T ATE555656T1 AT E555656 T1 ATE555656 T1 AT E555656T1 AT 06813607 T AT06813607 T AT 06813607T AT 06813607 T AT06813607 T AT 06813607T AT E555656 T1 ATE555656 T1 AT E555656T1
Authority
AT
Austria
Prior art keywords
analgesics
vision
inhibitors
reducing
eet
Prior art date
Application number
AT06813607T
Other languages
English (en)
Inventor
Bruce Hammock
Ahmet Bora Inceoglu
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE555656T1 publication Critical patent/ATE555656T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
AT06813607T 2005-08-19 2006-08-18 Verwendung von seh-hemmern als analgetika ATE555656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70974105P 2005-08-19 2005-08-19
PCT/US2006/032595 WO2007022509A2 (en) 2005-08-19 2006-08-18 Use of seh inhibitors as analgesics

Publications (1)

Publication Number Publication Date
ATE555656T1 true ATE555656T1 (de) 2012-05-15

Family

ID=37758492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06813607T ATE555656T1 (de) 2005-08-19 2006-08-18 Verwendung von seh-hemmern als analgetika

Country Status (6)

Country Link
US (1) US9119837B2 (de)
EP (1) EP1931201B1 (de)
JP (1) JP2009504785A (de)
AT (1) ATE555656T1 (de)
CA (1) CA2619768A1 (de)
WO (1) WO2007022509A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008526894A (ja) * 2005-01-10 2008-07-24 レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア Ｃｏｘ阻害剤および５−ｌｏｘ阻害剤の活性を助けるための可溶性エポキシドヒドロラーゼの阻害剤の使用
EP2219450A4 (de) * 2007-11-08 2012-01-25 Univ California Linderung neuropathischer schmerzen mit eets- und seh-inhibitoren
EP2334180A4 (de) * 2008-09-15 2013-07-03 Univ California LINDERUNG VON ERKRANKUNGEN MIT EINER KOMBINATION AUS WIRKSTOFFEN ZUR ERHÖHUNG DER KONZENTRATION AN EPOXYGENIERTEN FETTSÄUREN UND WIRKSTOFFEN ZUR ERHÖHUNG DER cAMP-KONZENTRATION
CA2756670A1 (en) 2009-03-26 2010-09-30 The Regents Of The University Of California Mesenchymal stem cells producing inhibitory rna for disease modification
US20110065756A1 (en) * 2009-09-17 2011-03-17 De Taeye Bart M Methods and compositions for treatment of obesity-related diseases
WO2011097221A2 (en) * 2010-02-02 2011-08-11 Children's Medical Center Corporation Methods of promoting tissue growth and tissue regeneration
WO2011130716A2 (en) 2010-04-16 2011-10-20 Access Pharmaceuticals, Inc. A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
US20130065936A1 (en) * 2010-05-14 2013-03-14 The Regents Of The University Of California Modulation of bioactive epoxy-fatty acid levels by phosphodiesterase inhibitors
CN103501821A (zh) 2011-03-08 2014-01-08 艾克塞斯制药公司 用于递送活性剂穿过生物膜的靶向纳米载体系统
WO2013138118A1 (en) * 2012-03-14 2013-09-19 The Regents Of The University Of California Treatment of inflammatory disorders in non-human mammals
US10024844B2 (en) 2012-12-20 2018-07-17 Hospital For Special Surgery Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2
WO2015048531A1 (en) 2013-09-26 2015-04-02 Beth Israel Deaconess Medical Center, Inc. Inhibition of sgk1 in the treatment of heart conditions
US10813894B2 (en) 2015-02-20 2020-10-27 The Regents Of The University Of California Methods of inhibiting pain
CN118750488B (zh) * 2024-06-07 2025-09-12 浙江大学 11,12-eet在制备促进组织修复和/或再生的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310525A (en) * 1981-01-23 1982-01-12 Nelson Research & Development Company Method of treatment of inflammation
US5445956A (en) 1993-08-13 1995-08-29 The Regents Of The University Of California Recombinant soluble epoxide hydrolase
US5505949A (en) * 1994-10-13 1996-04-09 Benitez; Juan E. Topical treatment for acne
US6531506B1 (en) * 1996-08-13 2003-03-11 Regents Of The University Of California Inhibitors of epoxide hydrolases for the treatment of hypertension
US6150415A (en) * 1996-08-13 2000-11-21 The Regents Of The University Of California Epoxide hydrolase complexes and methods therewith
US5955496A (en) 1996-08-13 1999-09-21 The Regents Of The University Of California Dihydroxy-oxy-eicosadienoates
US6174695B1 (en) * 1997-08-12 2001-01-16 The Regents Of The University Of California Epoxide hydrolase inhibitor methods
IL124118A (en) * 1998-04-16 2007-09-20 Yissum Res Dev Co Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, method for their synthesis and pharmaceutical compositions containing them
WO2000023060A2 (en) 1998-10-20 2000-04-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method of treating immunological disorders mediated by t-lymphocytes
US6422715B2 (en) * 1999-06-11 2002-07-23 Technology Creations, Inc. Apparatus for illuminating a portable electronic or computing device
FR2795645B1 (fr) * 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
WO2001091745A2 (en) * 2000-05-30 2001-12-06 The Brigham And Women's Hospital, Inc. Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
DE60222264T2 (de) 2001-06-29 2008-01-03 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Phenylpyrazolderivate als seh-inhibitoren
MXPA04011472A (es) * 2002-05-22 2005-02-14 Amgen Inc Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor.
US20050026844A1 (en) * 2003-04-03 2005-02-03 Regents Of The University Of California Inhibitors for the soluble epoxide hydrolase
JP2008526894A (ja) * 2005-01-10 2008-07-24 レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア Ｃｏｘ阻害剤および５−ｌｏｘ阻害剤の活性を助けるための可溶性エポキシドヒドロラーゼの阻害剤の使用

Also Published As

Publication number Publication date
CA2619768A1 (en) 2007-02-22
WO2007022509A2 (en) 2007-02-22
US20080249055A1 (en) 2008-10-09
US9119837B2 (en) 2015-09-01
EP1931201A4 (de) 2009-11-11
EP1931201A2 (de) 2008-06-18
EP1931201B1 (de) 2012-05-02
WO2007022509A3 (en) 2007-06-07
JP2009504785A (ja) 2009-02-05

Similar Documents

Publication Publication Date Title
ATE555656T1 (de) Verwendung von seh-hemmern als analgetika
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
IL258702B (en) A pump system for use with organ care systems
ATE539751T1 (de) Verwendung von brimonidine zur behandlung von stress assoziierten zuständen
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
SE0301882D0 (sv) New use I
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
TW200505508A (en) Methods of administering a dermatological agent to a subject
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
BRPI0510617A (pt) uso de expressão de il-17 para prever inflamação de pele; processos de tratamento
DE50207442D1 (de) Behandlung der akne mit lipoxygenase inhibitoren
MY149960A (en) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
ECSP109917A (es) Nuevos derivados de ácido azabifenilaminobenzoico
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
MY158428A (en) Topical composition for the treatment of actinic keratosis
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
UY27772A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
WO2006006167A3 (en) Compositions and methods for dermatological wound healing
NO20080781L (no) GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer